1-14 of 14
Curly Morris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation for Therapy-Related Myeloid Neoplasms Following Treatment for Myeloma

Sarah Lawless, Curly Morris, Dirk-Jan Eikema, Linda Kostner, Friedrich Stoelzel, Nicolaus Kröger, Uwe Platzbecker, Wolfgang Bethge, Peter Brossart, Renato Fanin, Jürgen Finke, Jurgen Kuball, Veronique Leblond, Emma Nicholson, Jakob Passweg, Daniele Avenoso, Jacques-Olivier Bay, Ali Bazarbachi, Dolores Caballero, Joanna Drozd-Sokolowska, Christof Scheid, Donal P. McLornan, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2022) 140 (Supplement 1): 4884–4885.
https://doi.org/10.1182/blood-2022-169326
Published: 2022
Journal Articles

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Sarah Lawless, MB BCH BAO (Hons), MRCP, FRCPath, Simona Iacobelli, PhD, Nina Knelange, Patrice Chevallier, MD, Didier Blaise, Noel-Jean Milpied, MD, Robin Foà, MD, Jan J Cornelissen, MD PhD, Bruno Lioure, MD, Victoria Potter, Xavier Poire, MD, Eefke J. Petersen, MD PhD, Matthew P. Collin, MD PhD, Stig Lenhoff, John Snowden, Stella Santarone, MD, Keith Wilson, FRCPath, MRCP, MBBS, Jose E. Guimaraes, MD PhD, Peter Dreger, Martin R. Schipperus, Curly Morris, Stefan Schönland, Ibrahim Yakoub-Agha, MD PhD, Laurent Garderet, Kroger Nicolaus, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3425.
https://doi.org/10.1182/blood-2018-99-113824
Published: 2018
Journal Articles

Second Autologous Stem Cell Transplantation in Poor Stem Cell Mobilizers Multiple Myeloma Patients

Matjaz Sever, MD PhD, Giulia Sbianchi, Simona Iacobelli, PhD, Steffie van der Werf, Wiktor-Jedrzejczak Wieslaw, Didier Blaise, Jane F. Apperley, FRCP, FRCPath, MD MBChB, Mohamad Mohty, MD PhD, Christof Scheid, MD, Keith Wilson, Nigel H Russel, Peter Kalhs, MD, Patrice Chevallier, MD, Mark Ringhoffer, MD, Guido Kobbe, MD, Jiri Mayer, Prof, MD SCs, Edgar Jost, Teresa Zudaire, Xaver Schiel, Cecilia Isaksson, Marek Trneny, MD, Stefan Schönland, MD, Curly Morris, Laurent Garderet, MD PhD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5515.
https://doi.org/10.1182/blood.V130.Suppl_1.5515.5515
Published: 2017
Journal Articles

Comparison of Haematopoietic Stem Cell Transplantation Approaches in Primary Plasma Cell Leukaemia

Sarah Lawless, MB BCH BAO (Hons) MRCP FRCPath, Iacobelli Simona, Anja van Biezen, Linda Koster, Patrice Chevallier, MD PhD, Didier Blaise, MD PhD, Roberto Foà, MD, Reza Tabrizi, MD, Nicolaas PM Schaap, MD, Stig Lenhoff, Nigel H. Russell, V, MD, Xavier Poiré, MD, Eefke Petersen, MD PhD, Jan J. Cornelissen, MD PhD, Paolo Di Bartolomeo, MD, Keith Wilson, FRCPath, MRCP, MBBS, Martin Schipperus, Bruno Lioure, MD, William Arcese, MD, Ghulam J Mufti, MD, John A Snowden, Jurgen Finke, MD, Curly Morris, MD, Laurent Garderet, MD, Nicolaus Kröger, MD, Stefan Schönland, MD
Journal: Blood
Blood (2016) 128 (22): 2293.
https://doi.org/10.1182/blood.V128.22.2293.2293
Published: 2016
Journal Articles

A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial

Gordon Cook, MD PhD, Cathy Williams, David A Cairns, Anna Hockaday, Jamie Cavenagh, John A Snowden, MD FRCP, FRCPath, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, Guy Pratt, MD, Sally Chown, Earnest Heartin, Sheila J.M. O'Connor, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Julia Brown, PhD, Curly Morris, MD
Journal: Blood
Blood (2015) 126 (23): 394.
https://doi.org/10.1182/blood.V126.23.394.394
Published: 2015
Journal Articles

Patient-Reported Outcomes (PRO) in the Setting of Relapsed Myeloma: The Influence of Treatment Strategies and Genetic Variants Predict Quality of Life and Pain Experience

Sam H Ahmedzai, MBChB BSc FRCP, John A Snowden, MD FRCP, FRCPath, Angela Cox, BA MA PhD, David A Cairns, Cathy D Williams, Anna Hockaday, Jamie Cavenagh, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Julia Brown, PhD, Curly Morris, MD, Gordon Cook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3180.
https://doi.org/10.1182/blood.V126.23.3180.3180
Published: 2015
Journal Articles

Outcomes Following Salvage Autologous Stem Cell Transplant (ASCT2) Vs Low Dose Alkylating Consolidation Therapy Following Bortezomib-Containing Re-Induction for Relapsed Multiple Myeloma (MM) May be Dependent on Age and Symptomatic Status Initiation of Re-Induction: Results from the Myeloma X (Intensive) Trial

John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, David A Cairns, Cathy Williams, A Hockaday, J. D. Cavenagh, MD MRCP, John A Snowden, MD FRCP, FRCPath, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, Guy Pratt, MD, Sally Chown, Earnest Heartin, Sheila J.M. O'Connor, Julia Brown, PhD, Curly Morris, MD, Gordon Cook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1981.
https://doi.org/10.1182/blood.V126.23.1981.1981
Published: 2015
Journal Articles

The Role Of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In Patients With POEMS Syndrome: A Retrospective study Of The Plasma Cell Disorders Subcommittee Of The Chronic Malignancy Working Party Of The EBMT

Gordon Cook, MD, PhD, Laurent Garderet, MD, Simona Iacobelli, Ph. D, Curly Morris, MD, Nikolaus Kroeger, MD, Anja van Biezen, StatAnalyst, M Rovira, Jenny Byrne, Dominique Bordessoule, Giuseppe Leone, M.D., Arnon Nagler, MD, Mark Cook, Laurence Legros, MD, PhD, Gert J. Ossenkoppele, R Gacria Sanz, Jennifer Hoek, Luca Castagna, MD
Journal: Blood
Blood (2013) 122 (21): 415.
https://doi.org/10.1182/blood.V122.21.415.415
Published: 2013
Journal Articles

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

Gösta Gahrton, Simona Iacobelli, Bo Björkstrand, Ute Hegenbart, Astrid Gruber, Hildegard Greinix, Liisa Volin, Franco Narni, Angelo Michele Carella, Meral Beksac, Alberto Bosi, Giuseppe Milone, Paolo Corradini, Stefan Schönland, Kristina Friberg, Anja van Biezen, Hartmut Goldschmidt, Theo de Witte, Curly Morris, Dietger Niederwieser, Laurent Garderet, Nicolaus Kröger
Journal: Blood
Blood (2013) 121 (25): 5055–5063.
https://doi.org/10.1182/blood-2012-11-469452
Published: 2013
Journal Articles

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Curly Morris, MD, Simona Iacobelli, Gosta Gahrton, MD, Laurent Garderet, MD, Mary Drake, MBBCh, MD, Anja van Biezen, Mohamad Mohty, Didier Blaise, MD, Xavier Poiré, M.D, Marie José Kersten, Noel-Jean Milpied, MD, Stig Lenhoff, MD, PhD, Nigel H. Russell, MD, J.ürgen Finke, T. M. de Witte, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2008.
https://doi.org/10.1182/blood.V118.21.2008.2008
Published: 2011
Journal Articles

A Comparison of Two Different Reduced Intensity Conditioning (RIC) Allograft Strategies In Patients with Multiple Myeloma, An EBMT Analysis

Firoozeh Sahebi, Laurent Garderet, Simona Iacobelli, Anja van Biezen, Gösta Gahrton, Nicolaus Kröger, Theo de Witte, Curly Morris
Journal: Blood
Blood (2010) 116 (21): 3512.
https://doi.org/10.1182/blood.V116.21.3512.3512
Published: 2010
Journal Articles

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Laurent Garderet, Simona Iacobelli, Philippe Moreau, MD, Mamoun Dib, Denis Caillot, Dietger W Niederwieser, MD, Tamas Masszi, MD, PhD, Jean Fontan, MD, Mauricette Michallet, Alois Gratwohl, MD, Giuseppe Milone, MD, Chantal Doyen, Brigitte Pegourie, Roman Hajek, Philippe Casassus, MD, Brigitte Kolb, Carine Chaleteix, Bernd Hertenstein, Francesco Onida, MD, Heinz Ludwig, MD, marie Christiane Vekemans, Nicolas Ketterer, MD, Anne Daguenel, Norbert C. Gorin, MD, PhD, jean Luc Harousseau, Theo de Witte, Curly Morris, Gosta Gahrton
Journal: Blood
Blood (2010) 116 (21): 3043.
https://doi.org/10.1182/blood.V116.21.3043.3043
Published: 2010
Journal Articles

Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT.

Gosta Gahrton, MD, PhD, Bo Bjorkstrand, MD, PhD, Simona Iacobelli, Statistician, Ute Hegenbart, MD, Astrid Gruber, MD, PhD, Hildegard Greinix, MD, Liisa Volin, MD, Franco Narni, MD, Pellegrino Musto, MD, Meral Beksac, MD, Alberto Bosi, MD, Giuseppe Milone, MD, Paolo Corradini, MD, Hartmut Goldschmidt, MD, Theo de Witte, MD, Curly Morris, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2009) 114 (22): 52.
https://doi.org/10.1182/blood.V114.22.52.52
Published: 2009
Journal Articles

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma.

Rakesh Popat, MBBS, Heather E. Oakervee, MRCPath, Nicola Curry, MBBS, Nicola Foot, BSc, Curly Morris, FRCP, Mary Drake, MRCPath, Samir Agrawal, PhD, Patricia Smith, RGN, David Schenkein, MD, Dixie-Lee Esseltine, MD, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2554.
https://doi.org/10.1182/blood.V106.11.2554.2554
Published: 2005